LRSAM1
Basic information
Region (hg38): 9:127451489-127503499
Links
Phenotypes
GenCC
Source:
- Charcot-Marie-Tooth disease axonal type 2P (Supportive), mode of inheritance: AD
- Charcot-Marie-Tooth disease axonal type 2P (Strong), mode of inheritance: AR
- Charcot-Marie-Tooth disease axonal type 2P (Strong), mode of inheritance: AD
- Charcot-Marie-Tooth disease axonal type 2P (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Charcot-Marie-Tooth disease, axonal, type 2P | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 20865121; 22012984; 22781092 |
ClinVar
This is a list of variants' phenotypes submitted to
- Charcot-Marie-Tooth disease axonal type 2P (28 variants)
- Inborn genetic diseases (5 variants)
- Charcot-Marie-Tooth disease (4 variants)
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LRSAM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 134 | 135 | ||||
missense | 323 | 336 | ||||
nonsense | 11 | 11 | 22 | |||
start loss | 1 | |||||
frameshift | 15 | 11 | 26 | |||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 13 | 21 | ||||
splice region | 26 | 26 | 3 | 55 | ||
non coding | 23 | 131 | 46 | 200 | ||
Total | 31 | 37 | 357 | 272 | 50 |
Highest pathogenic variant AF is 0.0000329
Variants in LRSAM1
This is a list of pathogenic ClinVar variants found in the LRSAM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-127451542-C-T | Charcot-Marie-Tooth disease axonal type 2P | Benign/Likely benign (May 13, 2021) | ||
9-127451550-G-A | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 12, 2018) | ||
9-127451556-C-T | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 13, 2018) | ||
9-127451659-A-G | Charcot-Marie-Tooth disease axonal type 2P • not specified | Conflicting classifications of pathogenicity (Jan 12, 2018) | ||
9-127451716-C-T | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 12, 2018) | ||
9-127451779-G-A | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 13, 2018) | ||
9-127451784-CTTG-C | Charcot-Marie-Tooth disease type 2 | Uncertain significance (Jun 14, 2016) | ||
9-127451796-A-G | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 13, 2018) | ||
9-127451808-A-G | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 13, 2018) | ||
9-127451990-C-A | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Apr 27, 2017) | ||
9-127452039-C-T | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 13, 2018) | ||
9-127452082-C-T | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 13, 2018) | ||
9-127452135-C-T | Benign (Jun 20, 2018) | |||
9-127452529-G-T | Likely benign (Nov 18, 2020) | |||
9-127454489-G-GC | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Nov 08, 2023) | ||
9-127454509-G-A | not specified | Likely benign (Oct 08, 2015) | ||
9-127454528-A-T | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 09, 2024) | ||
9-127454532-C-T | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jan 16, 2024) | ||
9-127454533-G-A | Charcot-Marie-Tooth disease axonal type 2P | Likely benign (May 24, 2023) | ||
9-127454536-C-T | Charcot-Marie-Tooth disease axonal type 2P | Likely benign (Oct 15, 2020) | ||
9-127454540-T-C | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jun 23, 2022) | ||
9-127454543-C-T | Charcot-Marie-Tooth disease axonal type 2P • Inborn genetic diseases | Uncertain significance (Oct 18, 2023) | ||
9-127454544-G-A | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Jun 18, 2023) | ||
9-127454547-A-AGCGGAAACCCAGTGAGGAGGC | Charcot-Marie-Tooth disease axonal type 2P • Inborn genetic diseases | Uncertain significance (Aug 20, 2023) | ||
9-127454549-C-G | Charcot-Marie-Tooth disease axonal type 2P | Uncertain significance (Oct 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LRSAM1 | protein_coding | protein_coding | ENST00000323301 | 24 | 52016 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.10e-13 | 0.999 | 125631 | 0 | 117 | 125748 | 0.000465 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.407 | 399 | 423 | 0.944 | 0.0000283 | 4713 |
Missense in Polyphen | 130 | 137.64 | 0.94448 | 1525 | ||
Synonymous | -0.481 | 180 | 172 | 1.05 | 0.0000115 | 1357 |
Loss of Function | 3.00 | 29 | 52.4 | 0.553 | 0.00000270 | 573 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00181 | 0.00181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000273 | 0.000272 |
Finnish | 0.000157 | 0.000139 |
European (Non-Finnish) | 0.000328 | 0.000325 |
Middle Eastern | 0.000273 | 0.000272 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00148 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that mediates monoubiquitination of TSG101 at multiple sites, leading to inactivate the ability of TSG101 to sort endocytic (EGF receptors) and exocytic (HIV-1 viral proteins) cargos (PubMed:15256501). Bacterial recognition protein that defends the cytoplasm from invasive pathogens (PubMed:23245322). Localizes to several intracellular bacterial pathogens and generates the bacteria- associated ubiquitin signal leading to autophagy-mediated intracellular bacteria degradation (xenophagy) (PubMed:23245322, PubMed:25484098). {ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:23245322, ECO:0000269|PubMed:25484098}.;
- Disease
- DISEASE: Charcot-Marie-Tooth disease 2P (CMT2P) [MIM:614436]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:20865121, ECO:0000269|PubMed:22012984, ECO:0000269|PubMed:27615052, ECO:0000269|PubMed:27686364}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.143
Intolerance Scores
- loftool
- 0.809
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.63
Haploinsufficiency Scores
- pHI
- 0.386
- hipred
- Y
- hipred_score
- 0.683
- ghis
- 0.519
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.978
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lrsam1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- lrsam1
- Affected structure
- motor neuron
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- protein polyubiquitination;autophagy;protein catabolic process;negative regulation of endocytosis;viral budding;protein autoubiquitination;ubiquitin-dependent endocytosis;positive regulation of xenophagy;positive regulation of autophagosome assembly
- Cellular component
- cytoplasm;cytosol;membrane
- Molecular function
- ubiquitin-protein transferase activity;protein binding;metal ion binding;ubiquitin protein ligase activity